Public, NASDAQ:ABPI
NASDAQ Global Market
Orexigen® Announces Agreement From the FDA on a Special Protocol Assessment ...
Date: Tue, 07 Feb 2012 01:03:04 GMT
Tags:
Orexigen® Announces Agreement From the FDA on a Special Protocol Assessment ...
BioMedReports (subscription) - 17 hours ago
BioMedReports (subscription) - 17 hours ago
By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on February 6, 2012.
BiovaxID(R) Personalized Lymphoma Vaccine is Featured in Article Published in ...
Date: Mon, 06 Feb 2012 14:22:29 GMT
Tags:
BiovaxID(R) Personalized Lymphoma Vaccine is Featured in Article Published in ...
MarketWatch (press release) - Feb 6, 2012
MarketWatch (press release) - Feb 6, 2012
TAMPA, Fla. & MINNEAPOLIS, Feb 06, 2012 (BUSINESS WIRE) -- Biovest International, Inc. (otcqb:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (otcqb:ABPI), today announced that an article was published in HemOnc Today, ...
OneMedPlace Initiates Research Coverage on Biovest and BiovaxID(R ...
Date: Wed, 01 Feb 2012 14:45:58 GMT
Tags:
OneMedPlace Initiates Research Coverage on Biovest and BiovaxID(R ...
MarketWatch (press release) - Feb 1, 2012
MarketWatch (press release) - Feb 1, 2012
TAMPA, Fla., Feb 01, 2012 (BUSINESS WIRE) -- Biovest International, Inc. (otcqb:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (otcqb:ABPI), today announced that OneMedPlace, a biotechnology-focused research and media ...
Huge Volume for Accentia Biopharmaceuticals, Inc. (PINK:ABPI)
Date: Thu, 26 Jan 2012 14:37:50 GMT
Tags:
Huge Volume for Accentia Biopharmaceuticals, Inc. (PINK:ABPI)
HotStocked - Jan 26, 2012
HotStocked - Jan 26, 2012
by Kaloyan Gadzhev Jan 26, 2012 Tweet 0 Comments Yesterday Accentia Biopharmaceuticals, Inc. (PINK:ABPI, ABPI message board) finished the session with unusually high volume and a significant increase in price.
Accentia Biopharmaceuticals Inc : Biovest Prepares for EU Regulatory Meetings ...
Date: Fri, 20 Jan 2012 03:48:08 GMT
Tags:
Accentia Biopharmaceuticals Inc : Biovest Prepares for EU Regulatory Meetings ...
4-traders (press release) - Jan 20, 2012
4-traders (press release) - Jan 20, 2012
Biovest International, Inc. (OTCQB:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB:ABPI), today announced that the European Medicines Agency (EMA) has granted Small and Medium Sized Enterprise (SME) status to Biovest.
Biovest Prepares for EU Regulatory Meetings; SME Status Granted Providing ... - MarketWatch (press release)Yahoo! Finance: RSS feed not found
Date: Wed, 17 Nov 2010 13:45:00 GMT
Tags:
RSS feed not found. Please remove this RSS feed or check Yahoo! Finance for more symbols.